Session 14

Vaccines funding in Europe

Ensuring sustainability in a post-pandemic world

Organised by Sanofi

Immunisation affects more people than any other healthcare intervention globally and is estimated to prevent 4-5 million deaths annually. A necessary enabler for access to this vital instrument of population health is sustainable funding that can be made available in a timely manner.

Approaches to routine vaccine funding and the underlying budget-setting process vary greatly across European countries, affecting resilience of the overall vaccine eco-system and its flexibility to integrate new vaccines. The policy debate on how vaccines are funded has intensified due to the pandemic, highlighting the need for a more sustainable funding approach to strengthen immunisation infrastructures, secure uptake of routine vaccinations, and provide timely and equitable access to new vaccines.

Join us for this session to review differences in the funding of vaccines across Europe, discuss opportunities to ensure its prioritisation post-pandemic including routine investment into COVID-19 immunisation, and address approaches to support the strengthening of life-course immunisation systems as a critical component of robust pandemic preparedness plans.